Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Cutter

Showing results (271-280 of 296) with videos related to

Pageof 30
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2021
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSDBruce Ac Cree, Jeffrey L Bennett, Ho Jin Kim, et al.
Pediatrics|September 21, 2011
Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trialsLisa M Askie, Roberta A Ballard, Gary R Cutter, et al.
Brain : a Journal of Neurology|July 11, 2019
Early complement genes are associated with visual system degeneration in multiple sclerosisKathryn C Fitzgerald, Kicheol Kim, Matthew D Smith, et al.
Archives of Physical Medicine and Rehabilitation|August 28, 2018
Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical TrialsMarcas M Bamman, Gary R Cutter, David M Brienza, et al.
Lancet (London, England)|September 10, 2019
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trialBruce A C Cree, Jeffrey L Bennett, Ho Jin Kim, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 7, 2021
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learningKelly M Makielski, Alicia J Donnelly, Ali Khammanivong, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2021
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum DisorderRomain Marignier, Jeffrey L Bennett, Ho Jin Kim, et al.
The New England Journal of Medicine|July 28, 2006
Early inhaled nitric oxide therapy in premature newborns with respiratory failureJohn P Kinsella, Gary R Cutter, William F Walsh, et al.
Molecular Therapy Oncolytics|November 15, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Pageof 30

Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2021
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSDBruce Ac Cree, Jeffrey L Bennett, Ho Jin Kim, et al.
Pediatrics|September 21, 2011
Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trialsLisa M Askie, Roberta A Ballard, Gary R Cutter, et al.
Brain : a Journal of Neurology|July 11, 2019
Early complement genes are associated with visual system degeneration in multiple sclerosisKathryn C Fitzgerald, Kicheol Kim, Matthew D Smith, et al.
Archives of Physical Medicine and Rehabilitation|August 28, 2018
Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical TrialsMarcas M Bamman, Gary R Cutter, David M Brienza, et al.
Lancet (London, England)|September 10, 2019
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trialBruce A C Cree, Jeffrey L Bennett, Ho Jin Kim, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 7, 2021
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learningKelly M Makielski, Alicia J Donnelly, Ali Khammanivong, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2021
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum DisorderRomain Marignier, Jeffrey L Bennett, Ho Jin Kim, et al.
The New England Journal of Medicine|July 28, 2006
Early inhaled nitric oxide therapy in premature newborns with respiratory failureJohn P Kinsella, Gary R Cutter, William F Walsh, et al.
Molecular Therapy Oncolytics|November 15, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Pageof 30